Tudor Investment Corp
KROS icon

Tudor Investment Corp’s Keros Therapeutics KROS Stock Holding History

Tudor Investment Corp’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$309K Sell
28,007
-300
-1% -$4.63K ﹤0.01% 3118
2025
Q4 		$576K Buy
28,307
+8,782
+45% +$154K ﹤0.01% 2639
2025
Q3 		$309K Buy
+19,525
New +$288K ﹤0.01% 2959
2025
Q2 		– Sell
-19,858
Closed -$202K – 3716
2025
Q1 		$202K Buy
19,858
+4,527
+30% +$52.6K ﹤0.01% 2863
2024
Q4 		$243K Sell
15,331
-4,456
-23% -$232K ﹤0.01% 2723
2024
Q3 		$1.15M Buy
19,787
+9,430
+91% +$466K 0.01% 1533
2024
Q2 		$473K Sell
10,357
-6,646
-39% -$357K 0.01% 1829
2024
Q1 		$1.13M Buy
17,003
+7,560
+80% +$448K 0.01% 1276
2023
Q4 		$375K Buy
+9,443
New +$296K 0.01% 1935
2023
Q2 		– Sell
-17,666
Closed -$754K – 2799
2023
Q1 		$754K Buy
+17,666
New +$892K 0.01% 1374
2022
Q4 		– Sell
-12,829
Closed -$483K – 2716
2022
Q3 		$483K Buy
12,829
+636
+5% +$22K 0.01% 1429
2022
Q2 		$337K Buy
+12,193
New +$535K 0.01% 1490

Other funds holding KROS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return